Remove 2016 Remove FDA Remove Licensing Remove Nursing Homes
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – Spring

SQA

The Points is an upgraded version of Practice for Cosmetics Production Licensing , implemented in 2016, with more stringent inspection requirements. United States Food and Drug Administration (FDA) – Regulations and Guidances. United States Food and Drug Administration (FDA) – Recalls.

FDA 75
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

The Regulations were first issued with immediate effect in 2002 and were later revised in 2016. Compared to the 2016 revised version, the draft of the 2022 version includes 101 more articles to conform to the pharmaceutical policy reforms in the recent years and the Drug Administration Law revised in 2019.

FDA 91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

to tackle brittle bone disease NEA nursing homes highlighted as best in the country NWA healthcare continues evolution despite challenges NWA, Fort Smith metro hospitals take on maternal mortality with statewide collaboration CALIFORNIA California Skilled Nursing Facilities, Owner and Management Company Agree to $45.6

article thumbnail

Health Provider News

Hall Render

after cyberattack CHI St. migrants are a housing challenge. migrants are a housing challenge. migrants are a housing challenge. migrants are a housing challenge.

article thumbnail

Health Provider News – February 10, 2023

Hall Render

Dunleavy proposes extending Medicaid coverage for new mothers ARIZONA Banner Health pays $1.25M penalty over HIPAA failures from 2016 breach Arizona nursing school at risk of losing accreditation St. billion since pandemic U.S. billion since pandemic U.S. Blue Shield of California is counting on it.

article thumbnail

Health Provider News

Hall Render

Then Prospect Medical took over. institute focused on health equity Medical providers at D.C.’s

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. The FDA’s five reviews of teratogenic risk all came to the same conclusion.

FDA 105